Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company. The firm is mainly engaged in the development and commercialization of transformative immunology-based therapies for patients. The company was founded by Lonnie O. Moulder Jr on November 12, 2019 and is headquartered in Waltham, MA.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is headquartered Carlton, Australia.

Arcutis Biotherapeutics, Inc. engages in the development and commercialization of treatments for dermatological diseases. Its pipeline consists of topical treatments for plaque psoriasis, atopic dermatitis, hand eczema, vitiligo, scalp psoriasis, alopecia areata, and seborrheic dermatitis. The company was founded by Bhaskar Chaudhuri and David W. Osborne in June 2016 and is headquartered in Westlake Village, CA.

Elutia, Inc. is a biotechnology company, which engages in the provision of biologic products to improve compatibility between medical devices and the patients who need them. It operates through the following segments: Device Protection, Women's Health, and Cardiovascular. The Device Protection segment includes biological envelope that remodels into systematically connected, vascularized tissue for the long-term pocket protection of certain cardiac and neurostimulator implantable electronic vehicles. The Women's Health segment includes pre-hydrated, human acellular dermal matrix, or HADM, that is designed to enable rapid integration, cellular repopulation and rapid revascularization at the surgical site. The Cardiovascular segment includes a variety of viable matrices, produced with a proprietary process that is designed to protect and preserve native bone cells and reduce programmable cell death, for use in bone repair and fusion procedures. The Cardiovascular segment includes a portfolio of extracellular matrices that retain the natural composition of collagen, growth factors and proteins for use in vascular and cardiac repair and pericardial closure. The company was founded by Kevin L. Rakin and Charles Randal Mills on August 6, 2015 and is headquartered in Silver Spring, MD.

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Summit Midstream Corp. engages in developing, owning, and operating midstream energy infrastructure assets. It operates through the following segments: Rockies, Permian, Piceance, Mid-Con, and Northeast. The Rockies segment includes the midstream assets located in the Williston Basin and the DJ Basin. The Permian segment refers to the equity method investment in Double E. The Piceance segment is involved in the midstream assets located in the Piceance Basin. The Mid-Con segment focuses on the midstream assets located in the Barnett Shale and Arkoma Basin. The Northeast segments cover its previously owned midstream assets located in the Utica and Marcellus shale plays, and the previously owned equity method investment in Ohio Gathering that was focused on the Utica Shale. The company was founded on May 14, 2024 and is headquartered in Houston, TX.

SemiLEDs Corp. engages in the development, manufacture, and sale of light emitting diode chips, components, modules, and systems. Its products include blue, ultraviolet, green, white, and entertainment LEDs. It offers LED chips, EF flipchip LED series, LED components, UV LED, and lighting products. The firm's products are used for general lighting and specialty industrial applications, including including ultraviolet, or UV, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, germicidal and viricidal devices LED lighting for horticulture applications, architectural lighting, and entertainment lighting. The company was founded on January 4, 2005 and is headquartered in Miaoli, Taiwan.

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. It focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.

Iveda Solutions, Inc. enables cloud video surveillance via its Sentir data and video management platform, utilizing proprietary video streaming and big data storage technology. The firm provides services for telecommunications companies, datacenter operators, ISPs, and cable companies. Its products include IP Video products, IOT Devices & LAN Switches. The company was founded by David Ly in 2003 and is headquartered in Mesa, AZ.